NR3C2 and fibrosis: This finding is also supported by non-diabetic models of aldosterone-independent and angiotensin 1 receptor-independent cardiac injury showing that myeloid MR signalling can promote cardiac fibrosis in the absence of an effect on hypertension [11,30].